31-Mar-2023 - Helmholtz-Zentrum Dresden-Rossendorf e. V.

Nanobiosensor Developed for Detecting SARS-CoV-2

New sensor technology breakthrough against the pandemic

Infection and immunity status of the population are considered key parameters for handling pandemics. For this purpose, detecting antigens and antibodies is of great importance. The devices currently used for this purpose - what are known as point-of-care (POC) devices- are one option for rapid screening. Their sensitivity, however, needs further improvement. Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have been successful in such improvement by developing a nanobiosensor based on gold nanowires. Originally only intended for the detection of COVID-19-associated antigens and antibodies, the biosensor is also transferable to other biomarkers.

It is by now known from numerous studies that for detecting SARS-CoV-2, what are referred to as POC lateral flow tests (LFT) are a good and precise alternative to the reverse transcriptase-polymerase chain reaction, commonly known as PCR tests. The numerous advantages of LFT over PCR testing include rapid detection, on-site testing, low cost, and operation without laboratory equipment.

The greatest shortcoming of POC biosensors, however, is that their sensitivity is dependent on viral load. At a high viral load, sensitivity is one hundred percent, whereas at a low viral load, sensitivity may fall below ten percent. This can lead to false negative test results. The HZDR researchers’ aim was to develop sensor systems that can also be used for detecting low virus loads while providing quick and accurate results.

To do so, Dr. Larysa Baraban and her team at the HZDR-Institute of Radiopharmaceutical Cancer Research utilized nano wires made of gold, which can be employed to detect various biomolecules such as enzymes, proteins and antibodies. This approach was combined with electrochemical impedance spectroscopy, a technique that provides information on various processes at the electrode-electrolyte interface, including charge transfer, diffusion transport and formation of an electrical double layer, as well as on the properties of the measurement system. This includes solution resistance and roughness or porosity of the electrode surface.

“In our work, we have developed a nanoscopic biosensor chip consisting of six pairs of interlocking gold nanowire devices for detecting SARS-CoV-2 antigens and antibodies,” says Baraban of the project. “This makes it possible to detect both COVID-19-associated antigens and corresponding antibodies that appear during and after infection with the virus. We assume that the method is also transferable to other biomarkers and pathogens. The functional layer targeting the biomolecule must be modified accordingly for this purpose.”

Considerations and discussions are currently underway with the industry on how the sensor can be manufactured in large quantities at low cost.

Helmholtz-Zentrum Dresden-Rossendorf e. V.

Recommend news PDF version / Print

Share on

Facts, background information, dossiers
  • coronaviruses
  • point-of-care diagnosis
  • gold nanowires
  • Covid-19-detection
  • lateral flow test
  • electrochemical imp…
More about HZDR
  • News

    Precise X-ray thermometer for warm dense matter

    Warm dense matter (WDM) measures thousands of degrees in temperature and is under the pressure of thousands of Earth's atmospheres. Found in many places throughout the universe, it is expected to have beneficial applications on Earth. However, its investigation is a challenge. Even the temp ... more

    Precise sample alignment under extreme conditions

    The exact angular alignment of sample materials for the determination of their physical properties under extreme conditions is often difficult. Engineer Stefan Findeisen and physicist Dr. Hannes Kühne from the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) have developed the "Rotax", a filigre ... more

    Synthesis against the clock

    Radiolabeled molecules, so-called radiotracers, help nuclear physicians to detect and precisely target tumors, which are often developing due to pathological changes in metabolic processes. Using positron emission tomography, a team of scientists at Helmholtz-Zentrum Dresden-Rossendorf (HZD ... more